ModivCare Inc. (MODVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0020
-0.0635 (-96.95%)
At close: Oct 17, 2025
ModivCare Revenue
ModivCare had revenue of $650.65 million in the quarter ending March 31, 2025, a decrease of -4.94%. This brings the company's revenue in the last twelve months to $2.75 billion, down -0.70% year-over-year. In the year 2024, ModivCare had annual revenue of $2.79 billion with 1.32% growth.
Revenue (ttm)
2.75B
Revenue Growth
-0.70%
P/S Ratio
0.00
Revenue / Employee
116.32K
Employees
23,675
Market Cap
28.71K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.79B | 36.42M | 1.32% |
| Dec 31, 2023 | 2.75B | 246.78M | 9.85% |
| Dec 31, 2022 | 2.50B | 507.50M | 25.41% |
| Dec 31, 2021 | 2.00B | 628.22M | 45.90% |
| Dec 31, 2020 | 1.37B | -141.27M | -9.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Northwest Biotherapeutics | 1.09M |
| AMJ Global Technology | 39.00 |
ModivCare News
- 2 months ago - Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing - Business Wire
- 2 months ago - Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital - Business Wire
- 2 months ago - MODIVCARE ALERT: Bragar Eagel & Squire, P.C. Continues Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 3 months ago - Modivcare Regains Compliance with Nasdaq Continued Listing Standard - Business Wire
- 4 months ago - Modivcare Celebrates Over a Decade of Serving Suffolk Community Member - Business Wire
- 4 months ago - ModivCare, Inc. (MODV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 months ago - Modivcare Releases 2024 Sustainability Report - Business Wire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ModivCare, Inc. (MODV) And Encourages Stockholders to Reach Out - Accesswire